ByteDance completes $290M fundraising for AI drug unit
ByteDance has completed a $290 million fundraising for its AI drugmaking unit after spinning it off, sources said. The unit is Shanghai-headquartered Anew Labs, which uses AI for drug discovery.
ByteDance has completed a $290 million fundraising for its AI drugmaking unit after spinning it off from the group, two people familiar with the matter said on Wednesday. Shanghai-based Anew Labs uses AI for drug discovery.